The Patent Finder

Enzon Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Enzon Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Enzon Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,807,436Recombinant host for producing L-asparaginase II
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 7,584,675Connector enabling multiple sampling of sealed environment
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,071,741Stable recombinant adenosine deaminase
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,741,283Adenosine deaminase anticancer therapy
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,506,060Lna Antisense Oligonucleotides for the Modulation of Myc Expression
Formerly held
Lapsed on the fee record
Ended Nov 29, 2024 · High confidence
Lapsed on the fee recordEnded Nov 29, 2024High confidence
US 7,939,507Potent LNA oligonucleotides for the inhibition of HIF-1a expression
Formerly held
Lapsed on the fee record
Ended May 10, 2023 · USPTO record
Lapsed on the fee recordEnded May 10, 2023USPTO record
US 7,846,911Oligomeric compounds for the modulation of HIF-1alpha expression
Formerly held
Lapsed on the fee record
Ended Dec 7, 2022 · USPTO record
Lapsed on the fee recordEnded Dec 7, 2022USPTO record
US 8,785,617Oligomeric compounds for the modulation of HIF-1A expression
Formerly held
Lapsed on the fee record
Ended Jul 22, 2022 · USPTO record
Lapsed on the fee recordEnded Jul 22, 2022USPTO record
US 7,737,125LNA antagonists targeting the androgen receptor
Formerly held
Lapsed on the fee record
Ended Jun 15, 2022 · USPTO record
Lapsed on the fee recordEnded Jun 15, 2022USPTO record
US 7,737,264Oligomeric compounds for the modulation HIF-1α expression
Formerly held
Lapsed on the fee record
Ended Jun 15, 2022 · USPTO record
Lapsed on the fee recordEnded Jun 15, 2022USPTO record
10 of 82 patents shown.
Pro members see all 82.
Pro members: see all 82 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited